Old Web
English
Sign In
Acemap
>
authorDetail
>
Chaitanya Kumar Kedari
Chaitanya Kumar Kedari
AstraZeneca
Mycobacterium tuberculosis
Biochemistry
Biology
Pharmacology
Potency
3
Papers
78
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis
2014
ACS Medicinal Chemistry Letters
Chaitanya Kumar Kedari
Nilanjana Roy Choudhury
Sreevalli Sharma
Parvinder Kaur
Supreeth Guptha
Manoranjan Panda
Kakoli Mukerjee
Vasanthi Ramachandran
Balachandra Bandodkar
Sreekanth Ramachandran
Subramanyam J. Tantry
Show All
Source
Cite
Save
Citations (2)
Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
2013
Bioorganic & Medicinal Chemistry Letters
Sreekanth Ramachandran
Manoranjan Panda
Kakoli Mukherjee
Nilanjana Roy Choudhury
Subramanyam J. Tantry
Chaitanya Kumar Kedari
Vasanthi Ramachandran
Sreevalli Sharma
V. K. Ramya
Supreeth Guptha
Vasan K. Sambandamurthy
Show All
Source
Cite
Save
Citations (30)
Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents.
2012
ACS Medicinal Chemistry Letters
Pravin S. Shirude
Beena Paul
Nilanjana Roy Choudhury
Chaitanya Kumar Kedari
Balachandra Bandodkar
Bheemarao G. Ugarkar
Show All
Source
Cite
Save
Citations (46)
1